Driving meniscus health forward

Third review meeting

The MEFISTO consortium met for the 3rd Review Meeting in the Hubrecht Institute, Developmental Biology and Stem Cell Research Institute in Utrecht. The project is nearing its end and the partners presented their work to EC representatives.
Final resorbable and non-resorbable bioactive meniscal implants are ready for preclinical testing, a morphology-based predictive treatment algorithm for meniscectomy patients has been developed, and a preliminary health-economic analysis has been performed.


This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 814444 (MEFISTO).